Vibliome Therapeutics

0 followers


Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.

Industries

Employees

11-50

Links


Org chart

Collapse
Gary A. Flynn
Co-Founder
Patrick Green
Director, Information Technology

Board & advisors

Keith Flaherty
Scientific Advisor
Eric Springman
Scientific Advisor
Ken Westover
Scientific Advisor
Kwok-Kin Wong
Scientific Advisor